PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsGentamicin
Gentamicin
Apogen, Bristagen, Garamycin, Genoptic, Gentacidin, Gentafair, Gentak, Pred, U-gencin (gentamicin) is a small molecule pharmaceutical. Gentamicin was first approved as Garamycin on 1982-01-01. It is used to treat bacterial eye infections, bacterial infections, bacterial skin diseases, central nervous system infections, and endocarditis amongst others in the USA. It is known to target transient receptor potential cation channel subfamily A member 1.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
musculoskeletal diseasesD009140
digestive system diseasesD004066
respiratory tract diseasesD012140
nervous system diseasesD009422
eye diseasesD005128
urogenital diseasesD000091642
cardiovascular diseasesD002318
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Gentamicin sulfate
Tradename
Company
Number
Date
Products
GARAMYCINMerck Sharp & DohmeN-050039 DISCN1982-01-01
1 products, RLD
GARAMYCINMerck Sharp & DohmeN-050425 DISCN1982-01-01
1 products
GARAMYCINMerck Sharp & DohmeN-050505 DISCN1982-01-01
1 products, RLD
Hide discontinued
Gentamicin sulfate
+
Prednisolone acetate
Tradename
Company
Number
Date
Products
PRED-GAllerganN-050586 DISCN1988-06-10
1 products, RLD
PRED-GAllerganN-050612 DISCN1989-12-01
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
amolg aunapproved drug other2019-03-15
celestone-gunapproved drug other2018-11-20
gentakANDA2022-01-28
gentamicinANDA2024-01-30
gentamicin sulfateANDA2024-01-10
gentamicin sulfate cream usp, 0.1%ANDA2021-05-25
gentamicin sulfate in sodium chlorideANDA2023-01-26
gentamicin sulfate opth solutionANDA2022-06-17
isotonic gentamicin sulfateANDA2009-06-25
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
D06: Antibiotics and chemotherapeutics for dermatological use
D06A: Antibiotics for topical use
D06AX: Other antibiotics for topical use in atc
D06AX07: Gentamicin
J: Antiinfectives for systemic use
J01: Antibacterials for systemic use
J01G: Aminoglycoside antibacterials
J01GB: Other aminoglycosides in atc
J01GB03: Gentamicin
S: Sensory organ drugs
S01: Ophthalmologicals
S01A: Antiinfective ophthalmologics
S01AA: Antibiotics, ophthalmologic
S01AA11: Gentamicin
S02: Otologicals
S02A: Antiinfective drugs, otologic
S02AA: Antiinfectives
S02AA14: Gentamicin
S03: Ophthalmological and otological preparations
S03A: Antiinfectives, ophthalmologic and otologic
S03AA: Antiinfectives
S03AA06: Gentamicin
HCPCS
Code
Description
J1580
Injection, garamycin, gentamicin, up to 80 mg
Clinical
Clinical Trials
259 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544154413
Urinary tract infectionsD014552EFO_0003103N39.01414312
SepsisD018805HP_0100806A41.9241511
Surgical wound infectionD0135302261211
Diabetic footD017719EFO_1001459142118
AppendicitisD001064EFO_0007149K371258
Neonatal sepsisD000071074HP_004018722126
OsteomyelitisD010019EFO_0003102M861135
Wound infectionD014946134
Acoustic neuromaD009464HP_0009588224
Show 35 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Duchenne muscular dystrophyD020388EFO_000042922
InfertilityD007246HP_000078911
ObesityD009765EFO_0001073E66.911
OsteoporosisD010024HP_0000939M81.011
Diabetic retinopathyD003930EFO_000377011
Penetrating keratoplastyD01594811
MammaplastyD01646211
Respiratory insufficiencyD012131HP_0002093J96.911
CannabisD00218811
AnorexiaD000855HP_0002039R63.011
Show 2 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Vestibular diseasesD015837EFO_0009691H8133
Sensation disordersD012678H02.5933
Labyrinth diseasesD00775933
Bilateral vestibulopathyD00007169933
Critical illnessD01663822
CholangitisD002761HP_0030151K83.022
PregnancyD011247EFO_0002950Z33.111
LaparotomyD00781311
MalariaD008288EFO_0001068B5411
DiarrheaD003967HP_0002014R19.711
Show 38 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameGentamicin
INNgentamicin
Description
Gentamicin is an antibiotic used to treat several types of bacterial infections. This may include bone infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, and sepsis among others. It is not effective for gonorrhea or chlamydia infections. It can be given intravenously, by intramuscular injection, or topically. Topical formulations may be used in burns or for infections of the outside of the eye. It is often only used for two days until bacterial cultures determine what specific antibiotics the infection is sensitive to. The dose required should be monitored by blood testing.
Classification
Small molecule
Drug classantibiotics (Micromonospora strains)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O
Identifiers
PDB
CAS-ID1403-66-3
RxCUI1596450
ChEMBL IDCHEMBL3039597
ChEBI ID
PubChem CID3467
DrugBankDB00798
UNII IDT6Z9V48IKG (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
TRPA1
TRPA1
Organism
Homo sapiens
Gene name
TRPA1
Gene synonyms
ANKTM1
NCBI Gene ID
Protein name
transient receptor potential cation channel subfamily A member 1
Protein synonyms
ankyrin-like with transmembrane domains 1, Ankyrin-like with transmembrane domains protein 1, p120, Transformation-sensitive protein p120, Wasabi receptor
Uniprot ID
Mouse ortholog
Trpa1 (277328)
transient receptor potential cation channel subfamily A member 1 (Q8BLA8)
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Gentamicin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Gentamicin
+
Prednisolone
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 159,918 documents
View more details
Safety
Black-box Warning
Black-box warning for: Gentamicin, Gentamicin sulfate in sodium chloride, Isotonic gentamicin sulfate
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
6,818 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use